134 related articles for article (PubMed ID: 32069138)
41. Operational equivalence of bioimpedance indices and perometry for the assessment of unilateral arm lymphedema.
Ward LC; Czerniec S; Kilbreath SL
Lymphat Res Biol; 2009; 7(2):81-5. PubMed ID: 19522677
[TBL] [Abstract][Full Text] [Related]
42. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Kaufman DI; Shah C; Vicini FA; Rizzi M
Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
[TBL] [Abstract][Full Text] [Related]
43. Economic benefits of BIS-aided assessment of post-BC lymphedema in the United States.
Bilir SP; DeKoven MP; Munakata J
Am J Manag Care; 2012 May; 18(5):234-41. PubMed ID: 22694061
[TBL] [Abstract][Full Text] [Related]
44. A Comparison of Supine Versus Stand-on Bioimpedance Devices to Assess Breast Cancer-Related Lymphedema.
Mastick J; Smoot BJ; Paul SM; Kober KM; Hamolsky D; Madden LK; Conley YP; Dixit N; Hammer MJ; Fu MR; Miaskowski C
Lymphat Res Biol; 2021 Dec; 19(6):553-561. PubMed ID: 33567232
[No Abstract] [Full Text] [Related]
45. Implementation of Single-Tab Electrodes for Bioimpedance Spectroscopy Measures.
Donahue PMC; Crescenzi R; Du L; Donahue MJ
Lymphat Res Biol; 2020 Jun; 18(3):277-283. PubMed ID: 31536441
[No Abstract] [Full Text] [Related]
46. Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines.
Shah C; Vicini FA; Arthur D
Breast J; 2016 Nov; 22(6):645-650. PubMed ID: 27487985
[TBL] [Abstract][Full Text] [Related]
47. Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema: A Systematic Review.
Forte AJ; Huayllani MT; Boczar D; Ciudad P; Lu X; Kassis S; Parker AS; Moore PA; McLaughlin SA
Plast Surg Nurs; 2020; 40(2):86-90. PubMed ID: 32459756
[TBL] [Abstract][Full Text] [Related]
48. Multi-segment bioimpedance can assess patients with bilateral lymphedema.
Qin ES; Bowen MJ; James SL; Chen WF
J Plast Reconstr Aesthet Surg; 2020 Feb; 73(2):328-336. PubMed ID: 31515193
[TBL] [Abstract][Full Text] [Related]
49. Calibration and Electrical Validation of a BIS Portable System.
Alves J; Sousa F; Correia MV
Stud Health Technol Inform; 2018; 249():122-129. PubMed ID: 29866967
[TBL] [Abstract][Full Text] [Related]
50. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
51. Measurement of hand volume by bioelectrical impedance spectroscopy.
Ward LC; Dylke ES; Kilbreath SL
Lymphat Res Biol; 2012 Jun; 10(2):81-6. PubMed ID: 22720663
[TBL] [Abstract][Full Text] [Related]
52. Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care.
Koelmeyer LA; Borotkanics RJ; Alcorso J; Prah P; Winch CJ; Nakhel K; Dean CM; Boyages J
Cancer; 2019 Mar; 125(6):854-862. PubMed ID: 30521080
[TBL] [Abstract][Full Text] [Related]
53. Reference ranges for assessment of unilateral lymphedema in legs by bioelectrical impedance spectroscopy.
Ward LC; Dylke E; Czerniec S; Isenring E; Kilbreath SL
Lymphat Res Biol; 2011 Mar; 9(1):43-6. PubMed ID: 21417766
[TBL] [Abstract][Full Text] [Related]
54. Determining the precision of dual energy x-ray absorptiometry and bioelectric impedance spectroscopy in the assessment of breast cancer-related lymphedema.
Newman AL; Rosenthall L; Towers A; Hodgson P; Shay CA; Tidhar D; Vigano A; Kilgour RD
Lymphat Res Biol; 2013 Jun; 11(2):104-9. PubMed ID: 23772720
[TBL] [Abstract][Full Text] [Related]
55. Body fluid volumes measurements by impedance: A review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods.
Jaffrin MY; Morel H
Med Eng Phys; 2008 Dec; 30(10):1257-69. PubMed ID: 18676172
[TBL] [Abstract][Full Text] [Related]
56. Cole equation and parameter estimation from electrical bioimpedance spectroscopy measurements - A comparative study.
Ayllon D; Seoane F; Gil-Pita R
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():3779-82. PubMed ID: 19964815
[TBL] [Abstract][Full Text] [Related]
57. Lymphedema: Improving Screening and Treatment Among At-Risk Breast Cancer Survivors.
Reichart K
Clin J Oncol Nurs; 2017 Feb; 21(1):21-25. PubMed ID: 28107316
[TBL] [Abstract][Full Text] [Related]
58. Reliability of bioimpedance spectroscopy and tonometry after breast conserving cancer treatment.
Moseley A; Piller N
Lymphat Res Biol; 2008; 6(2):85-7. PubMed ID: 18564923
[TBL] [Abstract][Full Text] [Related]
59. Quantitative bioimpedance spectroscopy for the assessment of lymphoedema.
Ward LC; Czerniec S; Kilbreath SL
Breast Cancer Res Treat; 2009 Oct; 117(3):541-7. PubMed ID: 19082708
[TBL] [Abstract][Full Text] [Related]
60. The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for breast cancer related lymphedema.
Shah C; Vicini F; Beitsch P; Laidley A; Anglin B; Ridner SH; Lyden M
Lymphology; 2013 Dec; 46(4):184-92. PubMed ID: 25141461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
